Publications by authors named "Chengwei Bi"

Claim this Profile
S
SunRISe-4 perioperative safety and TURBT stratification.
Wei Luo, Sinan Yang, Chengwei Bi, Yong Yang, Zhiyu Shi

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of potential bladder cancer drug targets through Mendelian randomization and molecular docking.
Chengwei Bi, Kexun Li, Yong Yang, Yuanlong Shi, Guoying Zhang, Bing Zhao

Discov Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor: global perspectives on the variability of antibiotic prophylaxis practices in holep and AI-assisted optimization strategies.
Zhiyu Shi, SiNan Yang, Chengwei Bi, Yong Yang

World J Urol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of cyclic di-GMP in biomaterial-associated infections caused by commensal Escherichia coli.
Shanshan Li, Chengwei Bi, Bingquan Xiang, Zhonghui Wang, Hui Yang

PLoS One· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Surgical androgen deprivation therapy for prostate cancer in a patient with concurrent scrotal paget's disease.
Sinan Yang, Qiao Wang, Yuanlong Shi, Bo Peng, Jinye Yang, Chengwei Bi, Bin Zhao

Front Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of adrenocortical adenoma in systemic sclerosis: A case report.
Zongyan Luo, Yuanlong Shi, Jinye Yang, Yuanpeng Duan, Qiao Wang, Bin Zhao, Chengwei Bi

J Int Med Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of prognostic and diagnostic models utilizing immune checkpoint-related genes in public datasets for clear cell renal cell carcinoma.
Bin Zhao, Shi Fu, Yuanlong Shi, Jinye Yang, Chengwei Bi

Front Genet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of renal leiomyosarcoma with right atrial tumor embolus without cardiopulmonary bypass: a case report.
Yuanpeng Duan, Chengwei Bi, Guoying Zhang, Yapeng Xing, Yang Qin, Bin Zhao

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer.
Chen Hu, Yu Bai, Jun Li, Guoyin Zhang, Libo Yang, Chengwei Bi, Bin Zhao

BMC Urol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer.
Cheng-Wei Bi, Guo-Ying Zhang, Yu Bai, Bin Zhao, Hong Yang

Medicine (Baltimore)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of hepcidin and iron metabolism in the onset of prostate cancer.
Bin Zhao, Ruiqian Li, Gang Cheng, Zhiyao Li, Zhiping Zhang, Chengwei Bi

Oncol Lett· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway.
Bin Zhao, Yu-Lin Lu, Yong Yang, Li-Bing Hu, Yu Bai, Cheng-Wei Bi

Cancer Biomark· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Gli1-mediated prostate cancer cell proliferation by inhibiting the mTOR/S6K1 signaling pathway.
Hong Yang, Libing Hu, Zhimin Liu, Yang Qin, Ruiqian Li, Bin Zhao, Chengwei Bi

Oncol Lett· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis